vs
agilon health, inc.（AGL）与Globe Life（GL）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是Globe Life的1.0倍（$1.6B vs $1.6B），Globe Life净利率更高（17.3% vs -12.0%，领先29.4%），Globe Life同比增速更快（5.3% vs 3.1%），过去两年Globe Life的营收复合增速更高（4.1% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
Globe Life Inc.（股票代码：GL）是总部位于美国得克萨斯州麦金尼的金融服务控股公司，在纽约证券交易所上市，通过旗下全资子公司开展业务，主营人寿保险、年金产品及补充健康保险产品。
AGL vs GL — 直观对比
营收规模更大
AGL
是对方的1.0倍
$1.6B
营收增速更快
GL
高出2.3%
3.1%
净利率更高
GL
高出29.4%
-12.0%
两年增速更快
GL
近两年复合增速
-1.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.6B |
| 净利润 | $-188.9M | $270.5M |
| 毛利率 | — | — |
| 营业利润率 | -12.3% | — |
| 净利率 | -12.0% | 17.3% |
| 营收同比 | 3.1% | 5.3% |
| 净利润同比 | -78.5% | 6.3% |
| 每股收益（稀释后） | — | $3.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLGL
| Q1 26 | — | $1.6B | ||
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.4B | $1.5B | ||
| Q2 25 | $1.4B | $1.5B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.5B | $1.5B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.5B | $1.4B |
净利润AGLGL
| Q1 26 | — | $270.5M | ||
| Q4 25 | $-188.9M | $266.1M | ||
| Q3 25 | $-110.2M | $387.8M | ||
| Q2 25 | $-104.4M | $252.7M | ||
| Q1 25 | $12.1M | $254.6M | ||
| Q4 24 | $-105.8M | $255.2M | ||
| Q3 24 | $-117.6M | $303.0M | ||
| Q2 24 | $-30.7M | $258.4M |
毛利率AGLGL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 26.1% | ||
| Q2 24 | — | 23.3% |
营业利润率AGLGL
| Q1 26 | — | — | ||
| Q4 25 | -12.3% | 21.7% | ||
| Q3 25 | -9.1% | 31.5% | ||
| Q2 25 | -8.3% | 21.2% | ||
| Q1 25 | -1.4% | 21.4% | ||
| Q4 24 | -7.1% | 21.3% | ||
| Q3 24 | -9.2% | 26.3% | ||
| Q2 24 | -2.9% | 23.5% |
净利率AGLGL
| Q1 26 | — | 17.3% | ||
| Q4 25 | -12.0% | 17.5% | ||
| Q3 25 | -7.7% | 25.6% | ||
| Q2 25 | -7.5% | 17.1% | ||
| Q1 25 | 0.8% | 17.2% | ||
| Q4 24 | -6.9% | 17.4% | ||
| Q3 24 | -8.1% | 20.8% | ||
| Q2 24 | -2.1% | 17.9% |
每股收益（稀释后）AGLGL
| Q1 26 | — | $3.39 | ||
| Q4 25 | — | $3.28 | ||
| Q3 25 | — | $4.73 | ||
| Q2 25 | — | $3.05 | ||
| Q1 25 | — | $3.01 | ||
| Q4 24 | — | $3.00 | ||
| Q3 24 | — | $3.44 | ||
| Q2 24 | — | $2.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $183.8M |
| 总债务越低越好 | $35.0M | — |
| 股东权益账面价值 | $126.7M | $6.1B |
| 总资产 | $1.3B | — |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资AGLGL
| Q1 26 | — | $183.8M | ||
| Q4 25 | $173.7M | $314.7M | ||
| Q3 25 | $171.7M | $62.8M | ||
| Q2 25 | $171.4M | $116.7M | ||
| Q1 25 | $136.9M | $134.1M | ||
| Q4 24 | $188.2M | $85.0M | ||
| Q3 24 | $148.2M | $100.5M | ||
| Q2 24 | $109.5M | $100.6M |
总债务AGLGL
| Q1 26 | — | — | ||
| Q4 25 | $35.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AGLGL
| Q1 26 | — | $6.1B | ||
| Q4 25 | $126.7M | $6.0B | ||
| Q3 25 | $306.1M | $5.7B | ||
| Q2 25 | $408.9M | $5.4B | ||
| Q1 25 | $500.3M | $5.4B | ||
| Q4 24 | $471.0M | $5.3B | ||
| Q3 24 | $574.9M | $4.6B | ||
| Q2 24 | $676.6M | $5.2B |
总资产AGLGL
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $30.8B | ||
| Q3 25 | $1.6B | $30.5B | ||
| Q2 25 | $1.7B | $29.8B | ||
| Q1 25 | $1.9B | $29.7B | ||
| Q4 24 | $1.7B | $29.1B | ||
| Q3 24 | $2.1B | $29.6B | ||
| Q2 24 | $2.2B | $28.3B |
负债/权益比AGLGL
| Q1 26 | — | — | ||
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | — |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | — |
| 自由现金流率自由现金流/营收 | -1.5% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-119.0M | — |
8季度趋势，按日历期对齐
经营现金流AGLGL
| Q1 26 | — | — | ||
| Q4 25 | $-20.5M | $350.6M | ||
| Q3 25 | $-18.2M | $306.0M | ||
| Q2 25 | $-35.1M | $307.9M | ||
| Q1 25 | $-32.0M | $431.9M | ||
| Q4 24 | $16.4M | $336.9M | ||
| Q3 24 | $-7.7M | $340.6M | ||
| Q2 24 | $-18.7M | $374.1M |
自由现金流AGLGL
| Q1 26 | — | — | ||
| Q4 25 | $-23.5M | $330.1M | ||
| Q3 25 | $-21.3M | $208.7M | ||
| Q2 25 | $-38.3M | $295.0M | ||
| Q1 25 | $-35.8M | $420.1M | ||
| Q4 24 | $13.2M | $321.9M | ||
| Q3 24 | $-11.2M | $311.3M | ||
| Q2 24 | $-22.0M | $356.5M |
自由现金流率AGLGL
| Q1 26 | — | — | ||
| Q4 25 | -1.5% | 21.7% | ||
| Q3 25 | -1.5% | 13.8% | ||
| Q2 25 | -2.7% | 19.9% | ||
| Q1 25 | -2.3% | 28.4% | ||
| Q4 24 | 0.9% | 22.0% | ||
| Q3 24 | -0.8% | 21.4% | ||
| Q2 24 | -1.5% | 24.8% |
资本支出强度AGLGL
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 1.3% | ||
| Q3 25 | 0.2% | 6.4% | ||
| Q2 25 | 0.2% | 0.9% | ||
| Q1 25 | 0.3% | 0.8% | ||
| Q4 24 | 0.2% | 1.0% | ||
| Q3 24 | 0.2% | 2.0% | ||
| Q2 24 | 0.2% | 1.2% |
现金转化率AGLGL
| Q1 26 | — | — | ||
| Q4 25 | — | 1.32× | ||
| Q3 25 | — | 0.79× | ||
| Q2 25 | — | 1.22× | ||
| Q1 25 | -2.64× | 1.70× | ||
| Q4 24 | — | 1.32× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
GL
| Life premium | $853.2M | 55% |
| Health premium | $416.9M | 27% |
| Other | $289.5M | 19% |
